InterVA-4 as a public health tool for measuring HIV/AIDS mortality: a validation study from five African countries
dc.contributor.author | Byass, Peter | |
dc.contributor.author | Calvert, Clara | |
dc.contributor.author | Nakiyingi-Miiro, Jessica | |
dc.contributor.author | Lutalo, Tom | |
dc.contributor.author | Michael, Denna | |
dc.contributor.author | Crampin, Amelia | |
dc.contributor.author | Gregson, Simon | |
dc.contributor.author | Takaruza, Albert | |
dc.contributor.author | Robertson, Laura | |
dc.contributor.author | Herbst, Kobus | |
dc.contributor.author | Todd, Jim | |
dc.contributor.author | Zaba, Basia | |
dc.date.accessioned | 2022-03-11T06:07:43Z | |
dc.date.available | 2022-03-11T06:07:43Z | |
dc.date.issued | 2013 | |
dc.description.abstract | Reliable population-based data on HIV infection and AIDS mortality in sub-Saharan Africa are scanty, even though that is the region where most of the world’s AIDS deaths occur. There is therefore a great need for reliable and valid public health tools for assessing AIDS mortality. Objective: The aim of this article is to validate the InterVA-4 verbal autopsy (VA) interpretative model within African populations where HIV sero-status is recorded on a prospective basis, and examine the distribution of cause-specific mortality among HIV-positive and HIV-negative people. Design: Data from six sites of the Alpha Network, including HIV sero-status and VA interviews, were pooled. VA data according to the 2012 WHO format were extracted, and processed using the InterVA-4 model into likely causes of death. The model was blinded to the sero-status data. Cases with known pre-mortem HIV infection status were used to determine the specificity with which InterVA-4 could attribute HIV/AIDS as a cause of death. Cause-specific mortality fractions by HIV infection status were calculated, and a person-time model was built to analyse adjusted cause-specific mortality rate ratios. Results: The InterVA-4 model identified HIV/AIDS-related deaths with a specificity of 90.1% (95% CI 88.7 91.4%). Overall sensitivity could not be calculated, because HIV-positive people die from a range of causes. In a person-time model including 1,739 deaths in 1,161,688 HIV-negative person-years observed and 2,890 deaths in 75,110 HIV-positive person-years observed, the mortality ratio HIV-positive:negative was 29.0 (95% CI 27.1 31.0), after adjustment for age, sex, and study site. Cause-specific HIV-positive:negative mortality ratios for acute respiratory infections, HIV/AIDS-related deaths, meningitis, tuberculosis, and malnutrition were higher than the all-cause ratio; all causes had HIV-positive:negative mortality ratios significantly higher than unity. | en_US |
dc.identifier.citation | Peter Byass, Clara Calvert, Jessica Miiro-Nakiyingi, Tom Lutalo, Denna Michael, Amelia Crampin, Simon Gregson, Albert Takaruza, Laura Robertson, Kobus Herbst, Jim Todd & Basia Zaba (2013) InterVA-4 as a public health tool for measuring HIV/AIDS mortality: a validation study from five African countries, Global Health Action, 6:1, 22448, DOI: 10.3402/ gha.v6i0.22448 | en_US |
dc.identifier.issn | 1654-9716 (Print) | |
dc.identifier.issn | 1654-9880 (Online) | |
dc.identifier.uri | https://doi.org/10.3402/gha.v6i0.22448 | |
dc.identifier.uri | https://nru.uncst.go.ug/xmlui/handle/123456789/2672 | |
dc.language.iso | en | en_US |
dc.publisher | Global Health Action | en_US |
dc.subject | HIV/AIDS | en_US |
dc.subject | mortality | en_US |
dc.subject | Africa | en_US |
dc.subject | verbal autopsy | en_US |
dc.subject | InterVA | en_US |
dc.subject | Alpha Network | en_US |
dc.title | InterVA-4 as a public health tool for measuring HIV/AIDS mortality: a validation study from five African countries | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- nterVA-4 as a public health tool for measuring.pdf
- Size:
- 705.45 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: